THE STUDY AND METHODS USED TO INDUCE OBESITY IN LABORATORY ANIMALS: THEORETICAL AND PRACTICAL CONCERNS

Obesity is defined as a body mass index of over 30 kg / m2 and represents a significant health risk because it increases the risk of diabetes, cardiovascular disorders, stroke and colon cancer. The study of the mechanisms by which obesity induces physiological dysfunctions can be facilitated by the use of an animal experimental model. Induction of obesity in laboratory animals can be accomplished by administering monosodium glutamate that causes lesion of the ventromedial hypothalamic nucleus, by administering hypercaloric diets and using genetically modified rodents. The animal model should reproduce the genesis of obesity and its pathophysiological mechanisms encountered in humans. In the obesity study, hormonal parameters such as leptin and adiponectin can be quantified, also the degree of differentiation of adipose tissue in brown or white and anthropometric measurements, such as: Body Mass Index (BMI), Obesity Index (OI), and Specific Weight Gain Rates (g / kg) are performed

The epidemiological background of small ruminant lentivirus infection in goats from Romania

Background and Aim: Caprine arthritis-encephalitis (CAE) is an economically significant viral disease of goats caused by a small ruminant lentivirus (SRLV) belonging to Retroviridae family. This study aimed to summarize current information on the epidemiological status of SRLVs infection in the population of goats from Romania and to point out the CAE incidence throughout the 2008-2018 periods. Materials and Methods: An exhaustive review of the papers published in the international literature concerning the epidemiological status of CAE in Romania was carried out using electronic databases, and available statistical data from the World Organization for Animal Health (OIE) regarding the incidence of the disease between 2008 and 2018 were analyzed. Results: The true individual-level seroprevalence of CAE was estimated in 13 of 42 counties (31%) and ranged from 0.4% to roughly 40%. One hundred eighty-two outbreaks from 14 counties (33%) were reported, with a peak in 2010. Conclusion: The findings sourcing in the literature are very scarce and show disagreement with the situation reported by the national veterinary authorities. Lack of SRLVs screening policies represents the main obstacle in limiting the spread of the disease. Romania's National Sanitary Veterinary and Food Safety Authority should implement a program for diagnosis and surveillance of the disease to build a straightforward epidemiological picture that represents a prerequisite of any control and eradication program

Nanoentrapped polyphenol coating for sustained drug release from a balloon catheter

This review provides a synthesis of the last ten years of research on nanodelivery systems used for the delivery of essential oils (EOs), as well as their potential as a viable alternative to antibiotics in human and veterinary therapy. The use of essential oils alone in therapy is not always possible due to several limitations but nanodelivery systems seem to be able to overcome these issues. The choice of the essential oil, as well as the choice of the nanodelivery system influences the therapeutic efficacy obtained. While several studies on the characterization of EOs exist, this review assesses the characteristics of the nanomaterials used for the delivery of essential oils, as well as impact on the functionality of nanodelivered essential oils, and successful applications. Two classes of delivery systems stand out: polymeric nanoparticles (NPs) including chitosan, cellulose, zein, sodium alginate, and poly(lactic-co-glycolic) acid (PLGA), and lipidic NPs including nanostructured lipid carriers, solid lipid NPs, nanoemulsions, liposomes, and niosomes. While the advantages and disadvantages of these delivery systems and information on stability, release, and efficacy of the nanodelivered EOs are covered in the literature as presented in this review, essential information, such as the speed of emergence of a potential bacteria resistance to these new systems, or dosages for each type of infection and for each animal species or humans is still missing today. Therefore, more quantitative and studies should be conducted before the adoption of EOs loaded NPs as an alternative to antibiotics, where appropriate

Seroprevalence of Toxoplasma gondii in wild boars, red deer and roe deer in Poland

Little is known about the prevalence of Toxoplasma gondii in wild life, particularly game animals in Poland. Meat juice collected during the 2009/2010 and 2010/2011 hunting seasons from 552 red deer (Cervus elaphus), 367 wild boars (Sus scrofa) and 92 roe deer (Capreolus capreolus) was tested for T. gondii antibodies using the multi-species ID Screen Toxoplasmosis Indirect kit (IDvet, Montpellier, France). Antibodies to T. gondii were detected in 24.1% of red deer (95% CI: 20.7%, 27.8%), 37.6% of wild boar (95% CI: 32.8%, 42.7%) and 30.4% of roe deer (95% CI: 22.0%, 40.5%). To the authors’ best knowledge, this is the first epidemiological report of T. gondii prevalence in red deer, roe deer and wild boars in Poland. T. gondii is present in wildlife animal tissues and consumption of the game may be a potential source of infection for humans

Seroprevalence of

Little is known about the prevalence of Toxoplasma gondii in wild life, particularly game animals in Poland. Meat juice collected during the 2009/2010 and 2010/2011 hunting seasons from 552 red deer (Cervus elaphus), 367 wild boars (Sus scrofa) and 92 roe deer (Capreolus capreolus) was tested for T. gondii antibodies using the multi-species ID Screen Toxoplasmosis Indirect kit (IDvet, Montpellier, France). Antibodies to T. gondii were detected in 24.1% of red deer (95% CI: 20.7%, 27.8%), 37.6% of wild boar (95% CI: 32.8%, 42.7%) and 30.4% of roe deer (95% CI: 22.0%, 40.5%). To the authors’ best knowledge, this is the first epidemiological report of T. gondii prevalence in red deer, roe deer and wild boars in Poland. T. gondii is present in wildlife animal tissues and consumption of the game may be a potential source of infection for humans

Comparative evaluation of florfenicol and polymeric nanopar-ticles loaded with florfenicol against bacterial strains isolated from chickens: insights into antimicrobial resistance

Antimicrobial resistance (AMR) poses a significant threat to both human and animal health, necessitating the search for alternative antimicrobial agents and strategies. In this study, we aimed to identify and isolate clinical bacterial strains from chickens and evaluate their sensitivity to florfenicol, a common antimicrobial agent that is used exclusively in veterinary medicine, along with polymeric nanoparticles loaded with florfenicol at various concentrations. Three clinical bacterial strains were successfully isolated and identified from chicken presenting clinical signs. In order to assess their susceptibility, the isolated strains were subjected to a standard disc diffusion assay using florfenicol. Subsequently, polymeric nanoparticles loaded with florfenicol were tested at six different concentrations and compared their efficacy against the bacterial strains. Our results demonstrated that all three clinical bacterial strains exhibited varying degrees of resistance to florfenicol. Interestingly, the use of polymeric nanoparticles loaded with florfenicol did not display enhanced antimicrobial activity compared to the free drug. Notably, the efficacy of the loaded nanoparticles did not significantly vary with different concentrations of active substance. This study highlights the importance of exploring novel therapeutic approaches to combat antimicrobial resistance. The use of polymeric nanoparticles loaded with florfenicol presents a promising avenue for overcoming resistance mechanisms and improving the efficacy of antimicrobial treatments both in human and veterinary medicine. Further investigations are needed to elucidate the underlying mechanisms and optimize the formulation of polymer nanoparticles for enhanced therapeutic outcomes in combating AMR